Fibrinolytic System Changes in Liver Surgery: A Pilot Observational Study

Fibrinolytic System Changes in Liver Surgery: A Pilot Observational Study

Introduction: Bleeding occurs frequently in liver surgery. Unbalance between tissue plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1) concentrations might increase bleeding. Our aim was to analyze perioperative fibrinolytic changes during liver surgery.Materials and Methods:...

Full description

Bibliographic Details
Main Authors:	Agnese Ozolina, Janis Nemme, Arturs Ozolins, Lars J. Bjertnæs, Indulis Vanags, Janis Gardovskis, Ludmila Viksna, Angelika Krumina
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2018-09-01
Series:	Frontiers in Medicine
Subjects:	fibrinolysis liver surgery tissue plasminogen activator t-PA plasminogen activator inhibitor type 1 PAI-1
Online Access:	https://www.frontiersin.org/article/10.3389/fmed.2018.00253/full

Similar Items

PAI-1 and t-PA/PAI-1 complex potential markers of fibrinolytic bleeding after cardiac surgery employing cardiopulmonary bypass
by: Ozolina Agnese, et al.
Published: (2012-10-01)

Activation of Coagulation and Fibrinolysis in Acute Respiratory Distress Syndrome: a Prospective Pilot Study
by: Agnese Ozolina, et al.
Published: (2016-11-01)

Role of Shear Stress and tPA Concentration in the Fibrinolytic Potential of Thrombi
by: Claire S. Whyte, et al.
Published: (2021-02-01)

A Quantitative Investigation of Selected Reactions in the Fibrinolytic Cascade
by: Cook, P. Michael
Published: (2008)

The Central Role of Fibrinolytic Response in COVID-19—A Hematologist’s Perspective
by: Hau C. Kwaan, et al.
Published: (2021-01-01)

A study of the interaction between Helicobacter pylori and components of the human fibrinolytic system
by: A. Yarzábal, et al.
Published: (2000-09-01)

The Role of Fibrinolytic System in Health and Disease
Published: (2022)

Lercanidipine and Losartan Effects on Blood Pressure and Fibrinolytic Parameters
by: Tsung-Hsien Lin, et al.
Published: (2006-04-01)

Enhancement of single-chain urokinase activity by platelets
by: Baeten, Kim Marieke
Published: (2009)

A Narrative Review on Plasminogen Activator Inhibitor-1 and Its (Patho)Physiological Role: To Target or Not to Target?
by: Machteld Sillen, et al.
Published: (2021-03-01)

Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications
by: Niaz Mahmood, et al.
Published: (2018-02-01)

Plasminogen Receptors and Fibrinolysis
by: Lindsey A. Miles, et al.
Published: (2021-02-01)

Modulation of staphylokinase-dependent plasminogen activation by mono- and divalent ions
by: Yarzábal A., et al.
Published: (1999-01-01)

Association Between PAI-1 Activity Levels and t-PA Antigen with Glycemic Status in Prediabetic Population
by: Andi Fachruddin Benyamin, et al.
Published: (2016-11-01)

Decrease of fibrinolytic potential in the occurrence of cerebral ischemia
by: Vučković Biljana, et al.
Published: (2008-01-01)

Fibrin γ/γ' influences the secretion of fibrinolytic components and clot structure
by: Miriam Cantero, et al.
Published: (2019-11-01)

CALIX[4]ARENES METHYLENE BISPHOSPHONIC ACIDS EFFECT ON PLASMIN ACTIVITY
by: O. I. Yusova, et al.
Published: (2018-10-01)

Development and application of global assays of hyper‐ and hypofibrinolysis
by: Anton Ilich, et al.
Published: (2020-01-01)

Activated protein C plays no major roles in the inhibition of coagulation or increased fibrinolysis in acute coagulopathy of trauma-shock: a systematic review
by: Satoshi Gando, et al.
Published: (2018-06-01)

Effect of Fagonia arabica on thrombin induced release of t-PA and complex of PAI-1 tPA in cultured HUVE cells
by: Prutha D. Aloni, et al.
Published: (2016-07-01)

Fibrinolysis and bleeding of unknown cause
by: Dino Mehic, et al.
Published: (2021-05-01)

Acute fibrinolysis shutdown occurs early in septic shock and is associated with increased morbidity and mortality: results of an observational pilot study
by: Felix Carl Fabian Schmitt, et al.
Published: (2019-01-01)

The potentials of antiplasminogen monoclonal antibodies in fibrinolytic & angiogenesis system manipulation
by: Maleki A, et al.
Published: (2009-04-01)

The Contribution of the Urokinase Plasminogen Activator and the Urokinase Receptor to Pleural and Parenchymal Lung Injury and Repair: A Narrative Review
by: Torry A. Tucker, et al.
Published: (2021-02-01)

Structural Insight into the Two-Step Mechanism of PAI-1 Inhibition by Small Molecule TM5484
by: Machteld Sillen, et al.
Published: (2021-02-01)

Decreased fibrinolytic activity is associated with carotid artery stiffening in arterial hypertension
by: Cristiana Catena, et al.
Published: (2017-01-01)

Ca(2+)-dependent regulation of fibrinolytic system activation on fibrin(ogen) D-domains
by: T. A. Yatsenko, et al.
Published: (2017-10-01)

Studies on Inhibitors of Plasminogen Activator Inhibitor-1(PAI-1) and Inhibitors of PAI-1 Production as Antithrombotic Agents
by: Miyazaki, Hiroshi
Published: (2010)

Experimental and Clinical Evidence Supports the Use of Urokinase Plasminogen Activation System Components as Clinically Relevant Biomarkers in Gastroesophageal Adenocarcinoma
by: Gary Tincknell, et al.
Published: (2021-08-01)

Stability of Recombinant Tissue Plasminogen Activator at &#8722;30 &#176;C over One Year
by: Abdulmalik Alkatheri
Published: (2013-01-01)

Fibrinolysis: A Primordial System Linked to the Immune Response
by: Robert L. Medcalf, et al.
Published: (2021-03-01)

Tissue-Type Plasminogen Activator and Tenecteplase-Mediated Increase in Blood Brain Barrier Permeability Involves Cell Intrinsic Complement
by: Charithani B. Keragala, et al.
Published: (2020-12-01)

Fibrin Network Formation and Lysis in Septic Shock Patients
by: Julie Brogaard Larsen, et al.
Published: (2021-09-01)

HDL3, but not HDL2, stimulates plasminogen activator inhibitor-1 release from adipocytes: the role of sphingosine-1-phosphate
by: Mi-Hye Lee, et al.
Published: (2010-09-01)

Interactions of Lipoprotein(a) with the Plasminogen System: Mechanisms and Pathophysiological Consequences
by: FERIC, NICOLE T
Published: (2011)

Comparison of the in-vivo effect of two tranexamic acid doses on fibrinolysis parameters in adults undergoing valvular cardiac surgery with cardiopulmonary bypass - a pilot investigation
by: Zhen-feng Zhou, et al.
Published: (2021-02-01)

PLASMINOGEN ACTIVATOR INHIBITOR GENE POLYMORPHISM IN EVALUATION OF THE VARIOUS LOCALIZATION THROMBOSIS RISKS (PILOT STUDY)
by: A. I. Subbotovskaya, et al.
Published: (2015-10-01)

Precision targeting of the plasminogen activator inhibitor‐1 mechanism increases efficacy of fibrinolytic therapy in empyema
by: Galina Florova, et al.
Published: (2021-05-01)

SMTP (<it>Stachybotrys microspora </it>triprenyl phenol) enhances clot clearance in a pulmonary embolism model in rats
by: Hu Weimin, et al.
Published: (2012-01-01)

Fibrinolytic therapy for refractory COVID‐19 acute respiratory distress syndrome: Scientific rationale and review
by: Christopher D. Barrett, et al.
Published: (2020-05-01)